Report Categories
View AllRecent Articles
View All
REPL Replimune Group rises nearly 8 percent after reporting narrower than expected Q1 2026 quarterly loss
MTEN Mingteng CEO signals confidence in sustained longterm revenue growth during latest quarterly earnings briefing
CFGE CitizensPfdE has not published detailed quarterly earnings or performance metrics for the recent reporting period
STOK Stoke Therapeutics EPS beats estimates by 63 as losses narrow yet shares decline 147